Oprelvekin (Neumega)

Covered Uses:	All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria:
Required Medical Information:	Patient has experienced severe thrombocytopenia (e.g., platelet count less than equal to 20,000/mcL) from previous chemotherapy OR for patient is considered to be at high risk for the development of severe thrombocytopenia.
Age Restrictions:
Prescriber Restrictions:
Coverage Duration:	12 months
Other Criteria:
Excluded Drug Criteria:

Last Modified on 08/05/2010